Search Results - "Majowicz, Anna"
-
1
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
Published in Frontiers in immunology (16-09-2022)“…AAV gene transfer is a promising treatment for many patients with life-threatening genetic diseases. However, host immune response to the vector poses a…”
Get full text
Journal Article -
2
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1
Published in Molecular therapy (02-08-2017)“…In the gene therapy field, re-administration of adeno-associated virus (AAV) is an important topic because a decrease in therapeutic protein expression might…”
Get full text
Journal Article -
3
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitis
Published in World journal of gastroenterology : WJG (28-08-2012)“…AIM:To explore the anti-inflammatory potential of adeno-associated virus-mediated delivery of Tregitope 167 in an experimental colitis model.METHODS:The…”
Get full text
Journal Article -
4
Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo
Published in BMC gastroenterology (03-12-2012)“…Induced regulatory T (iTreg) lymphocytes show promise for application in the treatment of allergic, autoimmune and inflammatory disorders. iTreg cells…”
Get full text
Journal Article -
5
Gene and cell therapy based treatment strategies for inflammatory bowel diseases
Published in World journal of gastrointestinal pathophysiology (15-12-2011)“…Inflammatory bowel diseases(IBD)are a group of chronic inflammatory disorders most commonly affecting young adults.Currently available therapies can result in…”
Get full text
Journal Article -
6
701. Successful In Vivo Re-Administration of AAV with the Use of Two-Step AAV Injection
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
7
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs
Published in Molecular therapy. Methods & clinical development (13-09-2019)“…Currently, individuals with pre-existing neutralizing antibodies (NABs) against adeno-associated virus (AAV) above titer of 5 are excluded from systemic…”
Get full text
Journal Article -
8
-
9
Seroprevalence of Pre-Existing Nabs Against AAV1, 2, 5, 6 and 8 in South African Hemophilia B Patient Population
Published in Blood (13-11-2019)“…Introduction Several studies have shown that the induction of antibodies by natural exposure to various AAV serotypes can compromise the subsequent use of AAV…”
Get full text
Journal Article -
10
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5ch and AAV1
Published in Molecular therapy (02-08-2017)“…In the gene therapy field, re-administration of adeno-associated virus (AAV) is an important topic because a decrease in therapeutic protein expression might…”
Get full text
Journal Article -
11
-
12
-
13
310. Analysis of AAV5 Biodistribution and Viral Shedding in the Presence or Absence of Neutralizing Antibodies
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
14
Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery
Published in The journal of gene medicine (01-06-2013)“…Background Muscle represents an important tissue target for adeno‐associated virus (AAV) vector‐mediated gene transfer in muscular, metabolic or blood‐related…”
Get full text
Journal Article -
15
300. Changing the Route of Administration to Improve Liver Transduction by Recombinant AAV-Based Vectors
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
16
-
17
Mir-142-3p target sequences reduce transgene directed immunogenicity following intramuscular AAV vector-mediated gene delivery
Published in Frontiers in immunology (2013)“…Abstract only…”
Get full text
Journal Article -
18
Murine CD4 super(+)CD25 super(-) cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo
Published in BMC gastroenterology (01-01-2012)“…Background: Induced regulatory T (iTreg) lymphocytes show promise for application in the treatment of allergic, autoimmune and inflammatory disorders. iTreg…”
Get full text
Journal Article